News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3 Results
Type
Article (2)
Press Release (1)
Section
Business (3)
Drug Development (2)
Job Trends (1)
News (2)
Tag
Academia (1)
Alzheimer's disease (1)
Job creations (1)
Neuroscience (1)
NextGen Class of 2024 (1)
People (1)
Preclinical (1)
Real estate (1)
Startups (2)
Date
2021 (1)
2019 (2)
3 Results for "gabaeron".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
GABAeron Presents Promising Preclinical Data on Stem Cell-Based Therapy for Alzheimer’s Disease
GABAeron, Inc. GABAeron. today presented promising preclinical data on their first-in-class, iPSC-based cell therapy product for Alzheimer’s disease at the International Society for Stem Cell Research
October 27, 2021
·
5 min read
Business
Gladstone Institutes’ Robert Mahley Launches Alzheimer’s Biotech GABAeron
Robert Mahley, founder and president of Gladstone Institutes, an internationally-recognized expert on heart disease, cholesterol metabolism and Alzheimer’s disease, is launching a biotech company to focus on Alzheimer’s disease. The company is called GABAeron.
February 6, 2019
·
3 min read
·
Mark Terry
Bio NC
1Q2019 Life Science Growth Announcements
In the first quarter of 2019, more than 30 life science companies* announced expansions, new locations, increased funding, new trial and product launches and various other news pointing to a growing industry.
April 17, 2019
·
2 min read
·
Editorial Staff
